1,272
Views
8
CrossRef citations to date
0
Altmetric
Research Paper

Impact of second wave of COVID-19 pandemic on the hesitancy and refusal of COVID-19 vaccination in Puducherry, India: a longitudinal study

, , , & ORCID Icon
Pages 5024-5029 | Received 20 Sep 2021, Accepted 27 Oct 2021, Published online: 30 Nov 2021

References

  • WHO. WHO Coronavirus (COVID-19) dashboard | WHO Coronavirus (COVID-19) dashboard with vaccination data [Internet]. [ accessed 2021 Jul 14]. https://covid19.who.int/ .
  • World Health Organization. India: WHO Coronavirus disease (COVID-19) dashboard with vaccination data | WHO Coronavirus (COVID-19) dashboard with vaccination data [Internet]. [ accessed 2021 Jul 14]. https://covid19.who.int/region/searo/country/in .
  • Indian Council of Medical Research. Vaccine information, ICMR New Delhi - COVID-19 vaccine [Internet]. [ accessed 2021 Jul 14]. https://vaccine.icmr.org.in/covid-19-vaccine .
  • SAGE Working Group. Report of the SAGE Working Group on Vaccine Hesistancy. (Geneva: World Health Organization (WHO)). [accessed 2021 Jul 14]. https://www.who.int/immunization/sage/meetings/2014/october/1_Report_WORKING_GROUP_vaccine_hesitancy_final.pdf
  • Sallam M. COVID-19 vaccine hesitancy worldwide: a concise systematic review of vaccine acceptance rates. Vaccines. 2021;9(2):1–14. doi:10.3390/vaccines9020160.
  • Su Z, Wen J, Abbas J, McDonnell D, Cheshmehzangi A, Li X, Ahmad J, Šegalo S, Maestro D, Cai Y, et al. A race for a better understanding of COVID-19 vaccine non-adopters. Brain Behav Immun Health. 2020;9:1–3. doi:10.1016/j.bbih.2020.100159.
  • Bartsch SM, O’Shea KJ, Ferguson MC, Bottazzi ME, Wedlock PT, Strych U, McKinnell JA, Siegmund SS, Cox SN, Hotez PJ, et al. Vaccine efficacy needed for a COVID-19 coronavirus vaccine to prevent or stop an epidemic as the sole intervention. Am J Prev Med. 2020;59(4):493–503. doi:10.1016/j.amepre.2020.06.011.
  • Reiter PL, Pennell ML, Katz ML. Acceptability of a COVID-19 vaccine among adults in the United States: how many people would get vaccinated? Vaccine. 2020;38(42):6500–07. doi:10.1016/j.vaccine.2020.08.043.
  • Neumann-Böhme S, Varghese NE, Sabat I, Barros P, Brouwer W, Van Exel J, Schreyögg J, Stargardt T. Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19. Eur J Health Econ. 2020;21(7):977–82. doi:10.1007/s10198-020-01208-6.
  • Joshi A, Kaur M, Kaur R, Grover A, Nash D, El-Mohandes A. Predictors of COVID-19 vaccine acceptance, intention, and hesitancy: a scoping review. Front Public Health. 2021;9. doi:10.3389/fpubh.2021.698111.
  • Hickler B, Guirguis S, Obregon R. Vaccine special issue on vaccine hesitancy. Vaccine. 2015;34(33):4155–56. doi:10.1016/j.vaccine.2015.04.034.
  • Population Census. Puducherry (Pondicherry) district population census 2011-2021 [Internet]; 2011 [accessed 2021 Jul 14]. https://www.census2011.co.in/census/district/482-puducherry.html .
  • Department of Revenue and Disaster Management Puducherry. Vaccination summary - Covid-19 dashboard Puducherry [Internet]. [ accessed 2021 Jul 14]. https://covid19dashboard.py.gov.in/VaccinationReport
  • Ministry of Health and Family Welfare Government of India. 2021; COVID-19 vaccine communication strategy. (New Delhi, India).
  • Sarasty O, Carpio CE, Hudson D, Guerrero-Ochoa PA, Borja I. The demand for a COVID-19 vaccine in Ecuador. Vaccine. 2020;38(51):8090–98. doi:10.1016/j.vaccine.2020.11.013.
  • Harapan H, Wagner AL, Yufika A, Winardi W, Anwar S, Gan AK, Setiawan AM, Rajamoorthy Y, Sofyan H, Mudatsir M, et al. Acceptance of a COVID-19 vaccine in Southeast Asia: a cross-sectional study in Indonesia. Front Public Health. 2020;8. doi:10.3389/fpubh.2020.00381.
  • Lazarus JV, Ratzan SC, Palayew A, Gostin LO, Larson HJ, Rabin K, Kimball S, El-Mohandes A. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2021;27(2):225–28. doi:10.1038/s41591-020-1124-9.
  • Wong LP, Alias H, Wong P-F, Lee HY, AbuBakar S. The use of the health belief model to assess predictors of intent to receive the COVID-19 vaccine and willingness to pay. Hum Vaccines Immunother. 2020;16(9):2204–14. doi:10.1080/21645515.2020.1790279.
  • Associated Press. AP-NORC poll: half of Americans would get a COVID-19 vaccine. AP NEWS [Internet]; 2021 Apr 20 [accessed 2021 Jul 26]. https://apnews.com/article/donald-trump-us-news-ap-top-news-politics-virus-outbreak-dacdc8bc428dd4df6511bfa259cfec44 .
  • Kabir R, Mahmud I, Chowdhury MTH, Vinnakota D, Jahan SS, Siddika N, Isha SN, Nath SK, Hoque Apu E. COVID-19 vaccination intent and willingness to pay in Bangladesh: a cross-sectional study. Vaccines (Basel). 2021;9(5):416. doi:10.3390/vaccines9050416.
  • Hossain MB, Alam MZ, Islam MS, Sultan S, Faysal MM, Rima S, Hossain Md.A,Mamun AA. COVID-19 vaccine hesitancy among the adult population in Bangladesh: a nationally representative cross-sectional survey. medRxiv; 2021. 2021.04.23.21255844.
  • Ali M, Hossain A. What is the extent of COVID-19 vaccine hesitancy in Bangladesh?: a cross-sectional rapid national survey. medRxiv; 2021. 2021.02.17.21251917.
  • The Indian Express. India has a vaccine hesitancy challenge. [Internet]; 2021 Jul 4 [accessed 2021 Jul 26]. https://indianexpress.com/article/opinion/India-has-a-vaccine-hesitancy-challenge-7388907/ .
  • Machingaidze S, Wiysonge CS. Understanding COVID-19 vaccine hesitancy. Nat Med. 2021;16:1–2.
  • Arce JS, Warren SS, Meriggi NF, Scacco A, McMurry N, Voors M, Syunyaev G, Malik AA, Aboutajdine, S, Armand, A, et al. COVID-19 vaccine acceptance and hesitancy in low and middle income countries, and implications for messaging. medRxiv; 2021.
  • Ong SWX, Young BE, Lye DC. Lack of detail in population-level data impedes analysis of SARS-CoV-2 variants of concern and clinical outcomes. Lancet Infect Dis. doi:10.1016/S1473-3099(21)00201-2.
  • SARS-CoV-2 variants: the need for urgent public health action beyond vaccines (The lancet COVID-19 commission task force on public health measures to suppress the pandemic, 2021); https://covid19commission.org/public-health-measures

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.